Taken together, these results showed that OXP can induce infiltration of effector/memory and cytotoxic immune cells to recognize and eradicate residual tumor cells via TLR1/2-mediated signaling, indicating that TLR1/2 is critical to enhance the therapeutic efficacy of immunogenic chemotherapy. This evidence concerns the gene TLR1 and neoplasm.